MATTHEW W FOEHR Insider Trading $VKTX Viking Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATTHEW W FOEHR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW W FOEHR. MATTHEW W FOEHR is President and COO in LIGAND PHARMACEUTICALS INC ($LGND) and Sr. VP Technical Operations in CONNETICS CORP ($CNCT) and Director in RITTER PHARMACEUTICALS INC ($RTTR) and Director in Viking Therapeutics, Inc. ($VKTX).
MATTHEW W FOEHR in Viking Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: Director
Holdings: 46,250 shares
Current Value: $67,063
Latest Transaction: Mar 25 2021
$VKTX Market Capitalization: $31.36M
$VKTX Previous Close: $1.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MATTHEW W FOEHR in Viking Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CNCT, LGND, RTTR, VKTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | X | 1.50 | 20,000 | 30,000 | 0 | |
| Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | X | 1.50 | 20,000 | 30,000 | 46,250 | 26.3 K to 46.3 K (+76.19 %) |
| Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | X | 1.50 | 20,000 | 30,000 | 0 | |
| Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | X | 1.50 | 20,000 | 30,000 | 46,250 | 26.3 K to 46.3 K (+76.19 %) |
| Jun 30 2020 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Sell | S | 7.35 | 13,000 | 95,550 | 26,250 | 39.3 K to 26.3 K (-33.12 %) |
| Jan 03 2020 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 7.95 | 22,000 | 174,900 | 22,000 | |
| Jan 03 2019 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 8.32 | 22,000 | 183,040 | 22,000 | |
| Jan 03 2018 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 4.48 | 16,000 | 71,680 | 16,000 | |
| Jan 05 2017 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 1.19 | 16,000 | 19,040 | 16,000 | |
| Nov 15 2016 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | P | 1.21 | 13,000 | 15,678 | 39,250 | 26.3 K to 39.3 K (+49.52 %) |
| Apr 13 2016 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | P | 1.50 | 20,000 | 30,000 | 20,000 | |
| Apr 13 2016 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | P | 1.24 | 20,000 | 24,800 | 26,250 | 6.3 K to 26.3 K (+320.00 %) |
| Jan 06 2016 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 3.33 | 16,000 | 53,280 | 16,000 | |
| May 05 2015 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | P | 8.00 | 6,250 | 50,000 | 6,250 | 0 to 6.3 K |
| Apr 30 2015 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 8.00 | 20,786 | 166,288 | 20,786 |
Page: 1